Table 2.
Application of organic NPs in PTT and as PTT-based theranostic agents.
| Organic NPs type | Size | Photothermal efficacy | In vitro anti-cancer effect | Particles injection dosage of in vivo anti-cancer study | In vivo anti-cancer effect | Reference |
|---|---|---|---|---|---|---|
| ICG loaded in silk fibroin NPs | 165.9 nm | ΔT max 30 °C at the highest ICG concentration (20 ppm) laser power 1.5 W/cm2 | Dose-dependent cytotoxicity in MCF-7 and HeLa cells, up to 90% toxicity for particles concentration of 20 μg/mL | No information was provided on volume or dose. | Control over xenografted MCF-7 tumor growth | [122] |
| ICG loaded in PLGA NPs | 159 nm | ΔT max 20 °C, laser 1.0 W/cm2, ICG concentration 15 μM | 90% reduction in cell viability in MCF-7 cells incubated for 24 h after laser irradiation | N/A | N/A | [111] |
| ICG conjugated to PEG pH sensitive micelles | 30 nm at pH 7.4 | ΔT max 34 °C for highest concentration of micelles. Higher PTT at acidic pH | 100% toxicity towards A549 cells after laser irradiation (1 W/cm2, 5 min) | 1.5 mg/kg (equivalent ICG) | Hyperthermia (55 °C, 1 W/cm2, 5 min), control over xenografted A549 tumor growth | [123] |
| Diketopyrrole derivative containing fluorine and selenium | 60 nm (DLS), 50 nm (TEM) | Photothermal conversion efficiency 32% for unmodified particles, up to 62% for fluorine and selenide containing particles | Dose-dependent toxicity in A549 cells after laser irradiation | 2 mg/kg | PAI of the tumor. Xenografted A549 tumors were eradicated. | [121] |
| PEG-PLGA NPs loaded with croconaines | 180 nm | Photothermal conversion efficiencies between 32 and ∼35% in acidic solution (pH 6.5) | Dose-dependent reduction in cell viability (up to 90%) in MDA-MB-231 cells | 5 mg/kg | In vivo multispectral PAI; antitumor efficacy in xenografted MDA-MB-231 tumor | [115] |
| Peptide-croconaines self-assembled NPs | 20 nm at pH 7.4, 512 nm at pH 5.5 | ΔT max 58 °C (1 W/cm2, 5 min) | Toxicity in Hu7 cells after laser irradiation | 0.1 mL (2 mM) | In vivo NIR II imaging, PAI, hyperthermia (>40 °C), control over HepG2 tumor growth | [116] |
| Porphyrin-polymer NPs | 133 nm | Photothermal conversion efficiency of 66% | Dose-dependent cytotoxicity in 4T1 cells after laser irradiation | 0.04 mg | Hyperthermia (55 °C); control over 4T1 tumor growth | [124] |
| Porphyrin-diketopyrrole self-assembled particles | 120 nm | Photothermal conversion efficiency of ∼63% | Dose-dependent cytotoxicity in HeLa cells with up to 70% reduction in cell viability | 0.05 mg | Hyperthermia (60 °C); Eradication of tumor in xenografted HeLa tumors | [125] |
| Ultrasmall PPy NPs, PEG and PVA | 2 nm, size dependent on PVA concentration | Photothermal conversion efficiency of ∼33% at 808 nm and ∼42% at 1064 nm | Dose-dependent cytotoxicity in U87 cells after irradiation with either 808 nm or 1064 nm laser | 23 mg/kg | Fluorescence and PAI; hyperthermia (55 °C in 10 min, laser power 1.0 W/cm2); control over xenografted U87 tumor growth | [120] |
| Cancer cell membrane coated mesoporous poly dopamine NPs | 250 nm | Photothermal conversion efficiency ∼39% | Dose-dependent and laser power-dependent toxicity in RM-1 cells | 4 mg/kg for biodistribution study, no dose information for the PTT in vivo study | Hyperthermia (55 °C in 5 min); control over xenografted RM-1 tumor growth | [117] |
| Macrophage membrane coated poly dopamine NPs | 159.6 nm | Photothermal conversion efficiency of 27% | Laser power-dependent cytotoxicity in 4T1 cells | 10 mg/kg | Hyperthermia (ca. 50 °C); Control over 4T1 tumor growth and long term survival | [126] |
| Melanin NPs coated with a silica shell | 100–150 nm | Photothermal conversion efficiency of 60% after silica coating, ∼67% for melanin particles before coating | Dose-dependent toxicity in 4T1 cells after laser irradiation (1064 nm, 1.0 W/cm2, 5 min) | 0.1 mg | Control over tumor growth in 4T1 tumor model; hyperthermia (50 °C) | [127] |
| Semiconducting polymeric NPs two isoindigo modification | 170 nm | ΔT°C max 27.3 °C (808 nm laser, 0.5 W/cm2, 7 min) | 80% reduction in cell viability in 4T1 cells after incubation with 25 μg of particles followed by laser irradiation (808 nm, 1 W/cm2, 5 min) | 0.05 mg | 4T1 tumor eradication after laser irradiation (808 nm, 0.5 W/cm2, 6 min). Hyperthermia (65 °C) | [128] |
| Semiconducting polymeric NPs vinylene bonds in the backbone | 36 nm | Photothermal conversion efficiency of 71 ± 2% | Dose- and laser power-dependent reduction in cell viability of 4T1 cells after irradiation for 8 min at 0.3 or 0.5 W/cm2 | 6 mg/kg | Hyperthermia (50 °C); Eradication of 4T1 tumor after irradiation for 6 min at 0.3 W/cm2 | [78] |
The undefined abbreviations in the table: polyethylene glycol (PEG), poly(lactide-co-glycolide) (PLGA).